Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Axsome Therapeutics, Inc.. A complete text table follows the diagram.
Product sales are the core, with milestone and royalty revenue adding a smaller layer.
Swipe to explore
Labels and displayed flow values are reported filing values or exact disclosed subtotals.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Axsome Therapeutics revenue | 1 | $191M | $191.2M reported quarterly revenue |
| Product sales, net | 2 | $189M | 99% of total revenues |
| Royalty and milestone revenue | 2 | $1.8M | 1% of total revenues |
| From | To | Value |
|---|---|---|
| Axsome Therapeutics revenue | Product sales, net | $189M |
| Axsome Therapeutics revenue | Royalty and milestone revenue | $1.8M |